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doi:10.1016/j.ejvs.2010.07.018Abstract Objectives: To verify the usefulness and limitation of intravascular ultrasound
(IVUS) in endovascular aneurysm repair (EVAR).
Methods: A total of 112 consecutive patients, who underwent EVAR to treat abdominal aortic
aneurysms, were examined retrospectively. Of these, 33 patients were assigned to the IVUS
group because of renal failure, a suspected allergy to contrast agents or anatomical difficul-
ties; the remaining 79 patients were assigned to the non-IVUS group.
Results: Patients in the IVUS group required fewer intra-arterial contrast agents (IACAs) than
those in the non-IVUS group (67 34 ml vs. 123 50 ml; p< 0.01). Blood loss and operation
time were comparable between the two groups. No patients died within 30 days of the oper-
ation. Three major renal complications occurred in the non-IVUS group. Renal deterioration
evaluated by chronic kidney disease (CKD) stage was found to a greater extent in the non-IVUS
group.
Conclusions: IVUS is a powerful auxiliary method in EVAR for reducing the required volume of
contrast agents. The combination of IVUS and IACA usage showed good overall performance;
thus, we propose the routine use of IVUS in EVAR procedures.
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Table 1 Patients’ characteristics.
IVUS Non-IVUS p-value
Age
Gender
(Male/Female)
75.1  8.6 74.4  8.9 N.S.
AAA diameter(mm) 52.8  9.9 51.1 10.9 N.S.
Risks
Cardiac 5 (15%) 9 (11%) N.S.
Cerebrovascular 7 (21%) 5 (6%) 0.02
Respiratory 9 (27%) 5 (6%) <0.01
Renal 14(42%) 2(2%) <0.01
Device
Excluder 24 39
Zenith 9 40
Figure 1 Transducer of the IVUS was detected on the intra-
operative fluoroscopy. IVUS image showed the intra-aortic
structures.
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Refinements in endovascular techniques have steadily
improved perioperative survival rates among patients
undergoing endovascular aneurysm repair (EVAR).1 EVAR
procedures require the use of intra-arterial contrast agents
(IACA), which aid in verifying aortic aneurysm morphology
and in identifying the ostia of renal and hypogastric
arteries. However, IACA are not recommended for use in
patients with renal dysfunctions or allergies to contrast
agents. Since the 1990s, intravascular ultrasound (IVUS) has
been used as an alternative to IACA.2e4 Originally, IVUS
images had low accuracy,5e7 but recent improvements have
resulted in very high-quality images of intra-aortic struc-
tures, which makes the use of IACA almost unnecessary.8 An
additional advantage of IVUS is that it facilitates the
precise placement of stent grafts, because it is more
accurate in locating hypogastric arteries and renal
arteries,2 which have parallax from the anteroposterior
(A-P) view rather than from angiography.
We retrospectively studied 112 cases of EVAR performed in
patients with non-ruptured infrarenal abdominal aortic
aneurysms. The purpose of this study was to examine both
the usefulness and limitations of IVUS, and also whether using
IVUS in cases of EVAR can reduce the amount of IACA required
without lowering the quality of the procedure. Furthermore,
we aimed to provide a detailed description of the basic steps
of the IVUS procedure to highlight its ease of use.
Patients and Methods
At Morinomiya Hospital (Osaka, Japan), 112 consecutive EVAR
procedures were performed on patients with non-ruptured
infrarenal abdominal aortic aneurysms (AAA) between January
2008 and November 2008. IVUS (Volcano Visions, PV 8.2F:
Volcano Japan Inc., Tokyo, Japan) was used in 33 cases (i.e.,
the IVUS group) for the following reasons: (1) anatomical
difficulties (16 cases; criteria included neck length< 15 mm,
peripheral landing length< 10 mm, or overlapping aortic
branches, defined as any casewhere aortic branches could not
be clearly separated unless C-arm rotation of more than 45
was used), (2) renal dysfunction (14 cases; defined as serum
creatinine level> 1.4mg dl1) or (3) allergy to contrast agents
(three cases). The remaining 79patients receivedanEVARwith
IACA-only (i.e., the non-IVUS group). Age, gender, aneurysmal
diameter and co-morbid conditions of all patients are shown in
Table 1. We also examined the factor of aortic wall condition.
Shaggy aorta was defined by the presence of mural thrombus
more than 3/4th of the circumflex of the thoracic aorta or the
abdominal aneurysmal neck. Three shaggy aortas were
observed (two thoracic and one abdominal) in the IVUS group
and 21 (eight thoracic and 13 abdominal) in the non-IVUS
group. Follow-ups of all cases continued for 12e24 months,
postoperatively. No patients experienced severe allergic
reactions to the contrast agents.
Two kinds of commercially available devices were used
in this study: a Gore Excluder AAA endoprosthesis (W.L.
Gore and Associates, Newark, DE, USA) and a Zenith
endovascular graft (COOK Medical Inc. Bloomington, IN,
USA). There were no definite criteria that dictated device
selection. In general, we preferred to use the Excluder forAAA with angulated aortic morphology because of its flex-
ible stent framework. On the other hand, we preferred to
use the Zenith for AAA in cases of short aortic necks
because its bare top stent facilitated firmer fixation.
The IVUS procedure steps used are summarised here.
First, the bilateral common femoral arteries were exposed
and a 9-F sheath introducer e the lowest profile adjusted to
the 8.2-F of the outer diameter of the IVUS transducer e was
inserted retrograde. A soft guidewire was used to introduce
a calibrated pigtail catheter, graduated in centimetres, up
to the thoracic aortic arch. The guidewire was then replaced
with a stiff wire followed by IVUS insertion. IVUS was used to
locate the renal arteries and hypogastric arteries by mapping
them on the monitor; then, IVUS was switched to the cali-
brated catheter to determine the length of the main body.
IVUS was introduced using the monorail system. In patients
receiving IACA, a 4-F sheath was inserted into the left
brachial artery to introduce the 4-F pigtail catheter, which
was positioned with its tip near the ostium of the renal
artery. After deployment of the main body, the soft guide-
wire was cannulated into the contralateral limb. The
guidewire was replaced with the stiff wire, followed by the
IVUS insertion (Fig. 1). The length of the contralateral site
was determined by measuring the length from the edge of
Use of IVUS for Abdominal Aortic Aneurysms 561the main body to the site of the hypogastric ostium. Using
the same technique, we estimated the stent graft length
with the calibrated catheter. (Fig. 2) Finally, completion
angiography was used to check for proper alignment of the
stent graft and to confirm that there were no endoleaks.
In procedures without IVUS, IACA are usually required in
the following steps: (1) 20 ml of contrast agent from the
pigtail catheter for measuring the distance from the renal
artery to the ipsilateral iliac bifurcation before main body
delivery: (2) 15 ml for accurately measuring proximal non-
aneurysmal aortic neck length: (3) 10 ml from the femoral
sheath introducer system for taking the contralateral leg
measurement: (4) in the same way, 10 ml from the sheath
for taking the ipsilateral leg measurement (Zenith only) in
the same fashion as (3): and (5) 20 ml from the pigtail
catheter for the completion angiography. When we used
the contrast agent according to the procedure mentioned
above, patients in the non-IVUS group and IVUS group
required at least 65e75 ml and 0e20 ml of IACA, respec-
tively. However, our primary focus was to avoid type I
endoleak rather than reduce the amount of IACA used.
Consequently, additional IACA was used to perform
multiple completion angiographies in some cases.
Renal function was defined using the CKD (chronic
kidney disease) staging system (National Kidney Founda-
tion/Kidney Disease Outcomes Quality Initiative e NFK/
KDOQI).9 Severe renal deterioration was defined as more
than two down-staging.
Where appropriate, unpaired Student’s t-tests were
used to make comparisons between treatment groups.
Significance was defined as p< 0.05.Results
Patients in the IVUS group received significantly less
IACA than patients in the non-IVUS group (67 34 ml vs.
123 50 ml; p< 0.01). (Table 1) Furthermore, less IACA
(39 14 ml) was required for a subgroup of the IVUS group,
consisting of 17 patients with renal dysfunction or a sus-
pected allergy to IACA, for whom we specifically chose to
use IVUS to reduce their exposure to IACA.
As shown in Table 1, cerebrovascular disease, and
respiratory and renal dysfunctions were more often
co-morbid in the IVUS group - this indicates that patients in
this group were at higher risk for surgery.
Blood loss (IVUS vs. non-IVUS: 172 135 ml vs.
165 135 ml; p> 0.05) and operation time (IVUS vs. non-
IVUS: 157 45 min vs. 165 76 min; p> 0.05) were
comparable between the two treatment groups, indicating
that the IVUS procedure did not impose any additional
intra-operative surgical stress during the EVAR procedures.
No patients died within 30 days of the operation; there
were no IVUS manoeuvre-related complications. Two
patients, who had EVAR performed exclusively with IVUS,
received re-interventions during the follow-up period. Two
patients required dialysis after developing renal failure,
and one patient experienced a postoperative increase in
creatinine levels (up to 2.9 mg dl1) e all three of these
patients belonged to the non-IVUS group, had normal renal
function preoperatively and had shaggy abdominal and/or
thoracic aortas. In the IVUS group, no patients with renalinsufficiency experienced deterioration after the proce-
dure. CKD staging was examined in both groups. In the IVUS
group, five cases of down-staging (one case decreased by
two stages) and four cases of up-staging were found. In the
non-IVUS group, 29 cases of down-staging (4 cases
decreased 2 stages, and 1 case decreased 3 stages), and 14
cases of up-staging were observed. Renal deterioration was
found more frequently in the non-IVUS group (IVUS vs. non-
IVUS; 15% vs. 36%, pZ 0.02). In the subgroup of IVUS that
suffered renal dysfunction or contrast allergy (17 cases),
there were two cases of down-staging (one case decreased
by two stages) and two cases of up-staging (subgroup of
IVUS vs. non-IVUS; 11% vs. 36%, pZ 0.04).
EVAR was performed exclusively with IVUS in seven
cases. The average operation time was 134 108 min,
during which time 144 59 ml of blood was lost. Although
statistical comparisons were not possible, these values
were consistently lower than for the patients in the non-
IVUS group. There were one intra-operative wire trouble
and one postoperative complication observed in this
IACA-free group. The intra-operative wire trouble
occurred in an 86-year-old patient with a short aneu-
rysmal neck. We had planned to deploy a Palmaz stent
(Cordis Corporation, Bridgewater, NJ, USA) into the stent
graft trunk. However, the edge of stent was hooked on
the flow divider and did not expand completely. After
confirming the patient’s peripheral flow, we terminated
the procedure. The single postoperative complication
occurred in a 63-year-old female patient with renal
insufficiency. The patient was re-admitted to our hospital
after complaining of pain in her left lower extremity after
undergoing EVAR without IACA 16 days earlier. Her
ankleebracheal index (ABI) had dropped from 0.8 to 0.45
and an ultrasound revealed an occlusion in the left stent
graft leg. We performed a thrombectomy and found that
the stent had developed a kink. We also performed
balloon expansion for the kinked site.
Postoperative computed tomography (CT) angiography
revealed that the use of IVUS enabled accurate landing of
the devices within 5 mm of their targets in all 16 patients in
whom we encountered anatomical difficulties. In such
cases, we were able to use IVUS in combination with IACA
because patients had satisfactory renal functioning. The
use of IVUS allowed us to omit several steps of IACA,
although we had to use IACA to a greater extent for precise
device delivery in anatomically difficult cases. As a result,
there were no significant differences in the amount of IACA
used in the group requiring IVUS for anatomical reasons
(118 43 ml) and in the non-IVUS group (123 50 ml)
(p> 0.05).Discussion
The 8.2-F monorail system of IVUS is a simple and less-
invasive auxiliary method. Our analyses indicate that there
were no significant differences in operation time or blood
loss between patients in the IVUS and non-IVUS groups. In
addition, IVUS catheter manoeuvres themselves did not
cause any major adverse events. Usage of IVUS does not
appear to have any contraindications for EVAR procedures,
nor does IVUS have any obvious drawbacks. We encourage
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ness and convenience.
IACA plays two important roles in stent graft delivery:
facilitating detection of endoleaks and verifying aortic
morphology. Incomplete endovascular exclusion causes
increases in intrasac pressure, leading to a high risk of late
rupture.10,11 We confirmed the absence of type I endoleaks
by carefully observing any direct leakage into the aneu-
rysmal sac and by confirming any backflow from collateral
arteries (e.g., lumbar, inferior mesenteric and sacral
medial arteries) towards the sac.11 We also employed
completion angiography to reveal the aortic morphology of
the deployed stent graft.
Initially, IVUS was mainly used for determining graft
size.3,4 Commercial stent grafts have been improved since
their usage began, and are now made in a variety of sizes
adapted to a wide range of intra-operative situations. The
resolution in the early days of IVUS imaging was insufficient
for detecting aortic branches; one study found that both
arteries could only be detected in 63% of EVAR patients.5 By
2003, IVUS techniques had become so efficient that some
claimed that angiography was not necessary.8 However,
among the seven IACA-free cases of EVAR in this study, one
developed a leg occlusion 16 days after experiencing intra-
operative procedural difficulties. If we had used IACA, the
intra-operative procedures would have been easier and the
kinking would have been easily detected. Contrast-
enhanced ultrasonography could be useful in some cases for
detecting endoleaks, although it has some limitations;
obesity and bowel gas can interfere with scanning.
Furthermore, the examination is operator-dependent and
requires specific skills and training.12 We are considering
the combined use of IVUS and contrast-enhanced ultra-
sound in cases of contraindication regarding contrast
agents. Another weakness of IVUS is that it is not useful for
independently confirming type I endoleaks, which are the
most common cause of postoperative rupture.11 For these
reasons, we conclude that we cannot confirm graft exclu-
sion accuracy without performing completion angiography.
Proximal type I endoleak is sometimes a problem in
cases of hostile aneurysmal necks.13 Precise measurement
is critical for maintaining the landing area for as long as
possible. Slovut reports that the SOS catheter set in the
renal artery can minimise the number of cine runs needed
to verify graft positioning during deployment,14 which
results in a comparatively low renal artery occlusion rate
(0.6%). To avoid renal artery embolisation and dissection,
we did not use wire cannulation or balloon occlusion. In
addition, when we used the C-arm, we performed cranial
rotation to adjust the renal artery ostium parallax because
most infrarenal AAAs tended to meander in the ventral
direction. One of the potential benefits of combining IVUS
and IACA is the ability to double-check the precise position
of the stent graft.
Distal type I endoleaks caused by AAAs accompanied by
common iliac artery aneurysms can be very difficult to fix.
In such cases, we set the peripheral edge of the leg just
above the hypogastric artery ostium so that arterial flow
was maintained. A landing zone of at least 1 cm is neces-
sary, and precise placement is sometimes difficult because
the ostium of the hypogastric artery is separated from the
external iliac artery by the C-arm. In such cases, we usuallyused IVUS for detecting the ostium site e this can be done
without the use of IACA.
Another important use of IVUS is measuring the distance
between aortic branches. In many cases of AAA, iliac
arteries in the IACA images overlapped with the ostium of
the hypogastric artery. To produce images that show a clear
separation of the branches, it was necessary to swing the
C-arm at exaggerated angles that were difficult for opera-
tors to achieve and maintain. Rotation of the C-arm also
increases both patients’ and operators’ exposure to intra-
operative radiation. Thus, using IVUS saves time and
energy, and creates a safer work environment.
Thus far, no drawbacks of IVUS usage have been identi-
fied. We found that both the IVUS and non-IVUS groups had
no mortality within the 30-day postoperative period, and
that there were no major operation-related complications
in the IVUS group, despite its higher co-morbid risk.
We successfully reduced the use of IACA. Furthermore, it
is interesting to note that renal deterioration was found
more frequently in the non-IVUS group, indicating the
beneficial effect of IVUS usage. However, the limitation
regarding the renal function is related to the ambiguous
and operator-dependent criteria of assigning patients to
the IVUS group. Indeed, there was a rough threshold of
creatinine level (1.4 mg dl1). However, this should be
evaluated with glomerular filtration rate (GFR) and CKD
staging, preoperatively. We should take the causes of renal
dysfunction into account when evaluating results. There
are assumed to be two causes of renal dysfunction: neph-
rotoxicity in response to contrast agents and nephropathy
due to cholesterol crystal embolisation (CCE) e both can be
difficult to distinguish. Contrast agents induce renal vaso-
constriction and interfere with water and sodium absorp-
tion by the renal tubules, leading to increased vascular
resistance and decreased GFR.15 In cases of chronic renal
insufficiency, contrast agents are excreted more slowly,
which in turn increases the risk of nephrotoxicity.16
Shaggy aorta is thought to be a strong risk factor for
CCE.17 In the present study, all three individuals, who
experienced renal deterioration, had shaggy aortas above
their renal arteries. Because these patients had previously
demonstrated good renal function and belonged to the non-
IVUS group, it appears that CCE and the use of contrast
agents might have been responsible for these renal failures.
Previously, carbon dioxide (CO2) angiography was used
as an alternative method to IACA in patients with
pre-existing renal dysfunction.18,19 In the present study, we
opted to use IVUS for device deployment to reduce the
volume of contrast agent required for the procedure. In
addition, we used conventional IACA to perform the
completion angiography. Although CO2 angiography is not
currently used by many endovascular surgeons, its ability to
produce high-quality images and reduce the risk of
complications is noteworthy.18 In addition, some authors
report that CO2 angiography is highly sensitive in pin-
pointing endoleaks, which is possibly due to the fact that
CO2 fills the sac earlier due to its low viscosity.
19 However,
some negative reviews of CO2 angiography exist. For
example, Lee reports that renal arteries are not satisfac-
torily shown,18 whereas Chao points out that this technique
requires longer fluoroscopy and operating-room times and
increases exposure to radiation.19 Therefore, while it does
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IACA, it might successfully be combined with IVUS to
improve EVAR performance.
In conclusion, IVUS is a powerful auxiliary method in
EVAR for reducing the required volume of contrast agent, as
well as saving the time and labour required for rotating the
C-arm, thereby reducing unnecessary radiation exposure
among both patients and operators. The quality and
simplicity of IVUS imaging has improved over the past
decade e it is both an effective and comparatively stress-
free method. However, exclusive use of IVUS carries a risk
of complications because it is not possible to evaluate
endoleaks and stent alignment. Thus, we recommend the
routine use of IVUS during EVAR procedures, but stress that
IACA are usually a necessary component of this technique.
Furthermore, we suggest that use of these two methods
should be determined on a case-by-case basis.
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